Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) has received a distance separation analysis (DSA) from the City of Henderson with respect to Maple Leaf’s proposed site for a medical marijuana establishment-cultivation facility. The proposed site (see news release dated January 30, 2017) was reviewed by City of Henderson staff for compliance with the City of Henderson Title 19 – Medical Marijuana Establishment distance separation requirements as listed in Table 19.5.5-2 of the Henderson Development Code. Based on the findings in the DSA, the proposed site satisfies the minimum separation standards for protected uses and would be suitable for a Medical Marijuana Establishment – Cultivation Facility within the City’s boundaries. The proposed site meets the minimum buffer distance from protected uses as defined in NRS 453A and Chapter 19 of the City of Henderson Municipal Code.
The DSA is the most important step in transferring the existing cultivation permit held by BioNeva Innovations of Henderson, LLC (the “Permit”) to the proposed site. As the DSA has been completed, the next steps will require the Company to submit its building plans to the City of Henderson for approval of a Conditional Use Permit (“CUP”). If the Company is successful in obtaining a CUP, it can begin construction on the marijuana cultivation facility on the proposed site.
With the DSA in hand, the Company will now proceed to complete the purchase of the proposed site and to finalize its acquisition of the Permit, through the purchase of 100% of the shares of BioNeva.
“There are only 10 permitted cultivation facilities serving about 27 dispensaries and 6 production licensees in the City of Henderson. Maple Leaf is well on its way to becoming the 11th permitted cultivator in this area (not includes Las Vegas) and we believe attaining this status will add significant value to the Company” said Raymond Lai, President & C.E.O. of Maple Leaf.
Company’s 1st Shareholder Reception
Maple Leaf Green World held its first shareholder reception on the evening of February 4, 2017. The event was a great success, with over 150 people in attendance. The Company’s management team (including its project managers and chief growers from all three of its existing marijuana projects in Canada and the United States) was in attendance. The video of the event along with an interview with Bubba Kush will be available to view on our website on February 23, 2017.
About Maple Leaf Green World Inc.
Maple Leaf Green World Inc. is a public Canadian company that focuses on the cannabis industry in North America. With over 10 years of extensive greenhouse management experience, it applies its eco- agriculture knowledge and cultivation technology to produce contaminant -free organic cannabis products.
Maple Leaf’s long-term objective is to produce cannabis oil and export its products to approved countries.
Click here to connect with Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) to receive an Investor Presentation.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).